Research progress in oncolytic virus and immunotherapy for liver cancer / 新乡医学院学报
Journal of Xinxiang Medical College
; (12): 187-190, 2024.
Article
em Zh
| WPRIM
| ID: wpr-1022669
Biblioteca responsável:
WPRO
ABSTRACT
Liver cancer is one of the most common cancers,and its common surgical treatment methods include tran-scatheter arterial chemoembolization,radiofrequency ablation,and liver transplantation surgery.However,the treatment effect of these surgeries on patients with mid-to late-stage liver cancer is not ideal.In recent years,with the continuous development of tumor gene therapy and tumor immunology,tumor treatment methods have transitioned from traditional models to targeted onco-lytic virus therapy.With the advantages of fast replication,the oncolytic virus can kill tumor cells without damaging other normal cells and realize the targeted treatment of liver cancer through mechanisms such as activating the immune system and improving the tumor microenvironment.In addition,immunotherapy can reduce tumor recurrence and metastasis,thereby exerting therapeutic effects on liver cancer.This article reviews the research progress of oncolytic virus and immunotherapy for liver cancer,aiming to provide a reference for the clinical treatment of liver cancer.
Texto completo:
1
Índice:
WPRIM
Idioma:
Zh
Revista:
Journal of Xinxiang Medical College
Ano de publicação:
2024
Tipo de documento:
Article